Two Compound Heterozygous Were Identified in SLC26A4 Gene in Two Chinese Families With Enlarged Vestibular Aqueduct
- Author:
Yongbo YU
1
;
Yang YANG
;
Jie LU
;
Yaqiong JIN
;
Yeran YANG
;
Enyu HONG
;
Jin SHI
;
Feng CHEN
;
Shujing HAN
;
Ping CHU
;
Yongli GUO
;
Xin NI
Author Information
- Publication Type:Original Article
- Keywords: Hearing Loss; Vestibular Aqueduct; SLC26A4 Protein; Frameshift Mutation
- MeSH: Asian Continental Ancestry Group; Child; Clinical Coding; Computer Simulation; Deafness; Exons; Extravehicular Activity; Frameshift Mutation; Hearing Loss; Heterozygote; Humans; Introns; Mass Screening; Parents; Sequence Homology; Siblings; Vestibular Aqueduct
- From:Clinical and Experimental Otorhinolaryngology 2019;12(1):50-57
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVES: To investigate the genetic causes of hearing loss with enlarged vestibular aqueduct (EVA) in two children from unrelated two Chinese families. METHODS: Sanger sequencing of all coding exons in SLC26A4 (encoding Pendrin protein) was performed on the two patients, their sibling and parents respectively. To predict and visualize the potential functional outcome of the novel variant, model building, structure analysis, and in silico analysis were further conducted. RESULTS: The results showed that the proband from family I harbored a compound heterozygote of SLC26A4 c.1174A>T (p.N392Y) mutation and c.1181delTCT (p.F394del) variant in exon 10, potentially altering Pendrin protein structure. In family II, the proband was identified in compound heterozygosity with a known mutation of c.919-2A>G in the splice site of intron 7 and a novel mutation of c.1023insC in exon 9, which results in a frameshift and translational termination, consequently leading to truncated Pendrin protein. Sequence homology analysis indicated that all the mutations localized at high conservation sites, which emphasized the significance of these mutations on Pendrin spatial organization and function. CONCLUSION: In summary, this study revealed two compound heterozygous mutations (c.1174A>T/c.1181delTCT; c.919- 2A>G/c.1023insC) in Pendrin protein, which might account for the deafness of the two probands clinically diagnosed with EVA. Thus this study contributes to improve understanding of the causes of hearing loss associated with EVA and develop a more scientific screening strategy for deafness.
